publication venue for
- Using Natural Language Processing to Identify Different Lens Pathology in Electronic Health Records.. 153-160. 2024
- Development and Validation of the Low Vision Severely Constricted Peripheral Eyesight (LV-SCOPE) Questionnaire.. 70-79. 2023
- Thyroid Eye Disease (TED) and its Vision Threatening Manifestations in the Academy IRIS® Registry: 2014-2018.. 74-85. 2023
- Diabetic Retinopathy and Dementia Association, Beyond Diabetes Severity.. 90-98. 2022
- Within-Trial Cost-Effectiveness of an Adherence-Enhancing Educational Intervention for Glaucoma.. 216-227. 2022
- Role of Caspase-1 as a Biomarker of Ocular Surface Damage.. 74-83. 2022
- Longitudinal Associations Between Vision Impairment and the Incidence of Neuropsychiatric, Musculoskeletal, and Cardiometabolic Chronic Diseases.. 163-171. 2021
- The Impact of COVID-19 and Pandemic Mitigation Measures on Persons With Sensory Impairment.. 49-58. 2021
- Need for Retinal Detachment Reoperation Based on Primary Repair Method Among Commercially Insured Patients, 2003-2016.. 71-81. 2021
- Caring for Older Adults With Self-Reported Vision Impairment: Findings from the National Study of Caregiving.. 211-221. 2021
- The Michigan Retinal Degeneration Questionnaire: A Patient-Reported Outcome Instrument for Inherited Retinal Degenerations.. 60-68. 2020
- Cataract Surgery Complexity and Surgical Complication Rates Among Medicare Beneficiaries With and Without Dementia.. 27-38. 2020
- Sex Differences in the Repair of Retinal Detachments in the United States.. 284-294. 2020
- Ocular Manifestations and Burden Related to Sjögren Syndrome: Results of a Patient Survey.. 40-48. 2020
- Characteristics of Ophthalmology Trials Registered in ClinicalTrials.gov, 2007-2018.. 132-141. 2019
- Use of Bevacizumab and Ranibizumab for Wet Age-Related Macular Degeneration: Influence of CATT Results and Introduction of Aflibercept.. 385-394. 2019
- Caregiver Burden in Primary Congenital Glaucoma.. 106-114. 2019
- Choice of Primary Rhegmatogenous Retinal Detachment Repair Method in US Commercially Insured and Medicare Advantage Patients, 2003-2016.. 82-90. 2018
- Geographic and Demographic Variation in Use of Ranibizumab Versus Bevacizumab for Neovascular Age-related Macular Degeneration in the United States.. 157-166. 2017
- An Analysis of Medicare Reimbursement to Ophthalmologists: Years 2012 to 2013.. 133-140. 2017
- Trends in Hospitalization and Incidence Rate for Syphilitic Uveitis in the United States From 1998 to 2009.. 133-141. 2017
- Establishing a Regional Glaucoma Physician Collaborative to Improve Quality of Care.. 145-150. 2017
- Self-reported Receipt of Dilated Fundus Examinations Among Patients With Diabetes: Medicare Expenditure Panel Survey, 2002-2013.. 18-24. 2017
- Head-Mounted Display Technology for Low-Vision Rehabilitation and Vision Enhancement.. 26-32. 2016
- Cataract Surgery Complications and Revisit Rates Among Three States.. 130-138. 2016
- Defining a Minimum Set of Standardized Patient-centered Outcome Measures for Macular Degeneration.. 1-12. 2016
- Prospective Evaluation of Acupuncture as Treatment for Glaucoma.. 160:256-65. 2015
- Risk factors predictive of endogenous endophthalmitis among hospitalized patients with hematogenous infections in the United States.. 159:498-504. 2014
- Associations of candidate genes to age-related macular degeneration among racial/ethnic groups in the multi-ethnic study of atherosclerosis.. 156:1010-1020.e1. 2013
- Agreement of flicker chronoscopy for structural glaucomatous progression detection and factors associated with progression.. 155:983-990.e1. 2013
- Corneal nerve aberrations in bullous keratopathy.. 151:840-849.e1. 2011